Previous Article | Next Article 
The Journal of Neuroscience, October 1, 2001, 21(19):7587-7597
The C Terminus of the Ca Channel
1B Subunit
Mediates Selective Inhibition by G-Protein-Coupled Receptors
Arthur A.
Simen,
Chong C.
Lee,
Birgitte B.
Simen,
Vytautas P.
Bindokas, and
Richard J.
Miller
Department of Neurobiology, Pharmacology, and Physiology,
University of Chicago, Chicago, Illinois 60637
 |
ABSTRACT |
Inhibition of calcium channels by G-protein-coupled receptors
depends on the nature of the G
subunit, although the G
complex is thought to be responsible for channel inhibition. Ca currents in
hypothalamic neurons and N-type calcium channels expressed in HEK-293
cells showed robust inhibition by
Gi/Go-coupled galanin receptors (GalR1),
but not by Gq-coupled galanin receptors (GalR2). However, deletions in
the C terminus of
1B-1 produced Ca channels that were
inhibited after activation of both GalR1 and GalR2. Inhibition of
protein kinase C (PKC) also revealed Ca current modulation by GalR2.
Imaging studies using green fluorescent protein fusions of the C
terminus of
1B demonstrated that activation of the GalR2
receptor caused translocation of the C terminus of
1B-1
to the membrane and co-localization with G
q and PKC. Similar translocation was not seen with a C-terminal truncated splice variant,
1B-2. Immunoprecipitation experiments demonstrated that G
q interacts directly with the C terminus of the
1B
subunit. These results are consistent with a model in which local
activation of PKC by channel-associated G
q blocks modulation of the
channel by G
released by Gq-coupled receptors.
Key words:
Ca channels; G-proteins; G
q; C terminus; galanin; G-protein receptors; PKC
 |
INTRODUCTION |
Activation of G-protein-coupled
receptors (GPCRs) is one of the major ways in which neurons respond to
external signals. Activation of many GPCRs results in the inhibition of
voltage-dependent Ca channels. The resulting reduction in Ca influx is
a major mechanism by which neurons regulate the release of
neurotransmitters (Miller, 1998
). Activation of GPCRs produces several
different types of Ca channel inhibition. The best studied of these
processes is characterized by a slowing of Ca channel activation and is
voltage-dependent, the inhibition being relieved by a depolarizing
prepulse (Bean, 1989
; Hille, 1994
). It is thought that this type of
inhibition is effected through the direct interaction of G-protein

subunits with the pore-forming
1
subunit of the Ca channel (Herlitze et al., 1996
; Ikeda, 1996
; De Waard
et al., 1997
). Interaction of 
subunits with the I/II loop and C
terminus of the
1 subunit has been
demonstrated, although other regions of the channel appear to be
involved, including the N terminus and domain I (Zhang et al., 1996
;
Zamponi et al., 1997
; Page et al., 1998
; Simen and Miller, 1998
, 2000
;
Stephens et al., 1998
). This mechanism of Ca channel inhibition has
been described as "membrane-delimited," because it does not appear
to involve freely diffusible intermediates. It is interesting to note,
however, that the activation of GPCRs does not always produce
voltage-dependent inhibition of Ca channels (Bernheim et al., 1991
;
Taussig et al., 1992
; Shapiro and Hille, 1993
; Shapiro et al., 1994
;
Liu et al., 1995
; Margeta-Mitrovic et al., 1997
).
According to the above discussion, one would expect that the productive
activation of any GPCR would result in Ca channel inhibition by virtue
of the fact that G
subunits are released. However, Ca channel
inhibition appears to depend on the nature of the G
molecule with
which a receptor is coupled. Activation of G
i/G
o-coupled (Dolphin
and Scott, 1987
; Ikeda and Schofield, 1989
), G
z-coupled (Jeong and
Ikeda, 1998
), and G
s-coupled (Hille, 1994
) receptors generally
causes voltage-dependent inhibition of Ca channels, but the activation
of receptors coupled to other G
subunits (e.g., G
q/11) usually
does not (Shapiro and Hille, 1993
; Hille, 1994
; Shapiro et al., 1994
).
On the other hand, activation of G
q/11-linked receptors often
produces a slow, voltage-independent inhibition of Ca channels, the
mechanism of which has not been determined. Recently, for example, it
has been demonstrated that G
q mediates voltage-independent
inhibition of Ca channels produced by M1 muscarinic receptors (Haley et
al., 2000
), whereas activation of M2 receptors produces pertussis
toxin-sensitive voltage-dependent inhibition (Toselli et al.,
1995
).
We have tried to determine why activation of some GPCRs fails to
produce voltage-dependent Ca channel inhibition. Here we show that the
differential susceptibility of N-type Ca channels to G
i/G
o-
versus G
q-coupled galanin receptors depends on structural elements
in the C terminus of the Ca channel
1 subunit
and provide evidence that protein kinase C (PKC) may play an important
role in mediating these effects.
 |
MATERIALS AND METHODS |
Acute isolation of hypothalamic neurons. Acutely
isolated neurons from the hypothalamus were obtained from rat pups
10-16 d old. Rat pups were anesthetized and decapitated. The
hypothalamus was rapidly removed and chilled to 4°C by submerging it
in 4°C Ringer's solution (in mM: 126 NaCl, 26.2 NaHCO3, 1.0 NaH2PO4, 3.0 KCl, 1.5 MgSO4, 2.5 CaCl2, and 10 glucose) while bubbling with 95% O2 and 5%
CO2. The tissue was mounted in a vibratome (TPI), and 400 µm cuts were made though the hypothalamus
containing the arcuate nucleus. The brain slices were transferred to a
holding chamber containing Ringer's solution at 35°C for 1 hr.
Tissues were then enzymatically treated with papain (15 U/ml; Roche
Molecular Biochemicals, Indianapolis, IN) for 1 hr. Papain was then
inactivated by treating the tissue with ovomucoid. Brain slices were
returned to the holding chamber until needed.
Neurons from the arcuate nucleus of the hypothalamus were isolated by
micropunching the area just lateral to the third ventricle. Neurons
were dissociated by gentle mechanical trituration using multiple
pipettes of decreasing bore diameters. Cells were then plated onto
glass coverslips precoated with poly-L-lysine. Cells were
placed into a 35°C incubator and allowed to settle for a minimum of
30 min before electrophysiological recordings were made.
Receptor and
1 subunit plasmid preparation.
Rat galanin receptors 1 and 2 (GalR1 and GalR2) were cloned from a rat
hypothalamic cDNA library (Clontech, Cambridge, UK) using PCR. Forward
and reverse primers were designed from the reported sequences for GalR1
and GalR2 (GenBank accession numbers, U30290 and AF010318). The PCR
products were isolated and subcloned into pGemT-Easy (Promega, Madison,
WI). Multiple clones were sequenced with dRhodamine terminator cycle
sequencing mix (PerkinElmer Life Sciences, Emeryville, CA) and an
automated DNA sequencer (ABI 377; PerkinElmer Life Sciences). Error-free clones were selected and subcloned into a mammalian expression vector, pcDNA 3.1 (Invitrogen, San Diego, CA) or a modified
pIRES-EYFP vector (Clontech).
Calcium channel subunit cDNAs encoding
1B-1,
1B-2,
2/
, and
1b were kindly provided by SIBIA
Neurosciences. cDNAs encoding the various wild-type G-protein
subunits (G
i1, G
o, and G
q) and constitutively activated
G-protein
subunits (Q-to-L mutations to eliminate GTPase activity:
G
i1Q240L, G
oQ250L, and G
qQ209L) were provided by Ronald
Taussig (University of Michigan). cDNA for the
-opioid receptor
(
OR) was kindly provided by Dr. Graeme I. Bell (Howard Hughes
Medical Institute, University of Chicago).
Modifications in the C terminus of
1B-1 were
described previously (Simen and Miller, 2000
). The
1875-2339
construct was created by deleting the nucleotides coding for amino
acids (aa) 1875-2339 and adding a stop codon to the construct. The
construct
2037-2087 is a deletion of aa 2037-2087. The
2037-2087 construct was created by replacing the nucleotides coding
for residues 2037-2087 with a HindIII site, which codes for
the amino acids Arg and Leu. Each of the C-terminal constructs was
verified by DNA sequencing.
Transfections. Monolayers (<80% confluence) of HEK-293 or
tsA-201 cells were replated on the day of transfection. Plasmids were
transfected using Fugene 6 (Roche Molecular Biochemicals) per the
manufacturer's instructions or polyethyleneimine as previously described (Simen and Miller, 1998
). Twenty-four to 48 hr after transfection, cells were replated onto glass coverslips precoated with
poly-L-lysine. Calcium currents were recorded 36-72 hr
after transfection from CD8-positive or green fluorescence protein
(GFP)-positive cells. CD8-transfected cells were labeled with a 1:1000
dilution of microspheres coated with an antibody against the CD8
antigen (Dynal, Oslo, Norway).
Electrophysiological recordings. Total
Ba2+ currents were measured using the
tight-seal whole-cell patch-clamp technique. The coverslips were
mounted in a perfusion chamber and constantly perfused by a gravity
feed system with a modified HEPES-balanced salt solution (in
mM: 5 BaCl2, 143 tetraethylammonium
chloride, 1 MgCl2, 10 Hepes, and 10 glucose, pH
adjusted to 7.4 and osmolarity to 310 mOsm) to isolate the
Ba2+ current. Patch pipettes of 2-6 M
resistance were filled with a solution containing 135 mM
CsCl, 1 mM MgCl2, 10 mM
HEPES, 10 mM BAPTA, 14 mM phosphocreatine, 3.6 mM MgATP, 3.6 mM LiGTP, and 50 U/ml creatine
phosphokinase, adjusted to pH 7.3 with CsOH and 290 mOsm. Data were
digitized at 10 kHz and filtered at 2 or 5 kHz. Series resistance was
compensated
70%, and currents were leak-corrected on-line using a
P/5 protocol (Armstrong and Bezanilla, 1977
).
Currents were measured and recorded with an Axopatch 200B (Axon
Instruments) or EPC9 (Heka) amplifier using the Clampex program (pClamp
6 software suite; Axon Instruments) or the Pulse program (Heka). All
experiments and solutions were used at room temperature. Each coverslip
was used only once to prevent any possible effects of desensitization.
However, no evidence of desensitization from multiple applications of
galanin and its analogs was observed.
Unless otherwise noted, statistical analyses were performed using the
Kruskal-Wallis variant of the ANOVA test followed by Dunn's
post hoc test.
Measurement of [Ca]i with fura-2. After
isolating neurons as described above, cells were loaded with fura-2
methyl-ester (Molecular Probes, Eugene, OR; 3 µM fura-2
for 20 min at room temperature). Cells were then washed with a
HEPES-balanced salt solution (in mM: 140 NaCl, 10 HEPES, 2 CaCl2, 2 MgCl2, 5 KCl, and
10 glucose, pH 7.4 and adjusted to ~310 mOsm.) for 20 min to allow
for deesterification of Fura-2. Changes in free internal calcium
concentration ([Ca]i) were monitored using
digital video microfluorimetry. An intensified CCD camera (Hamamatsu,
Hamamatsu City, Japan) coupled to a Nikon (Mellville, NY) Diaphot
microscope and Metafluor software (Universal Imaging Corp., West
Chester, PA) was used to gather intensity values. Cells were excited at
340 and 380 nm using a 150 W Xe arc and computer-controlled filter
wheel. Ratio intensities were calibrated via an eight point curve
derived from imaging droplets of 50 µM fura-2 in
calibrated free calcium buffers (Molecular Probes). Ratio intensities
and calculated calcium concentrations from marked areas of interest
were logged to a computer. Drugs were bath-applied using a gravity feed
system at room temperature.
Fusion constructs. Fragments of the C terminus were
expressed as fusion proteins with GFP. The GFP-C1 construct consisted of GFP fused to aa 1768-2339 of the human
1B-1 Ca channel. The GFP-C2 construct
consisted of GFP fused to aa 1768-2237 of the
1B-2 Ca channel. The GFP-CC1 construct
consisted of GFP fused to aa 1871-2339 of
1B-1. The GFP-CC2 construct consisted of GFP fused to aa 1871-2237 of
1B-2. The GFP-CCC1
construct consisted of aa 2164-2339 of
1B-1 fused
to GFP. The GFP-N construct consisted of aa 1768-2109 of
1B-1 fused to GFP. The GFP-NN construct
consisted of aa 1768-2009 of
1B-1 fused to
GFP. The GFP-NNN construct consisted of aa 1768-1875
1B-1 fused to GFP. Each of these constructs
was constructed by ligating the appropriate fragment into the
XhoI and XbaI sites of the pEYCP-C1 vector (Clontech).
Immunoprecipitation experiments. tsA-201 cells were
transfected with GFP-C1, GFP-C2, GFP-CC1, GFP-CC2, or GFP-CCC1 in
combination with rat G
q, rat G
q*, rat GalR2, or rat µOR. Two to
3 d after transfection, cells were washed once and dissociated for
10 min in 2 ml of PBS. Cells were then centrifuged at 800 rpm for 8 min at 4°C in flat-sided 10 ml tubes. The cells were then resuspended in
500 µl of labeling medium devoid of methionine and cysteine (Life
Technologies, Gaithersburg, MD) and incubated for 20 min at 37°C. One
hundred fifty microcuries of ProMix (300 µCi/ml; Amersham Pharmacia
Biotech, Arlington Heights, IL) was then added, and cells were
incubated at 37°C for 3 hr. The cells were then centrifuged at 800 rpm for 8 min at 4°C and resuspended in 200 µl of lysis buffer (50 mM Tris, pH 8.0, 150 mM NaCl, 20 mM
iodacetamide, 5 mM KCl, 5 mM
MgCl2, 1% IGEPAL CA-630, and 20 U/ml
aprotinin), in addition to a protease inhibitor mixture (in µg/ml: 10 N-P-tosyl-L-arginine methyl
ester, 10 tosyl-L-phenylalanine-chloromethyl
ketone, 10 soybean trypsin inhibitor, 1 leupeptin, and 1 pepstatin A, final concentrations). The cells were lysed for 25 min on
ice and centrifuged at 10,000 × g for 10 min at 4°C.
Incorporation of radioactivity in total protein was determined as
TCA-precipitable counts in duplicates of 1 µl of lysate and used to
normalize input of lysates in immunoprecipitation experiments.
Samples were precleared by adding 60 µl of recombinant protein A
coupled to Sepharose CL6 beads (Repligen) to the lysates. The samples
were taken up to a total volume of 700 µl with TNNB (50 mM Tris, pH 8.0, 250 mM NaCl, 0.5% IGEPAL
CA-630, 0.5 mM PMSF, 0.02% NaN3,
0.1% BSA, and protease inhibitor mixture). The reactions were mixed on
a rotator for 1 hr at 4°C and were then centrifuged, and the
supernatants were mixed overnight at 4°C with fresh protein A-Sepharose and the appropriate antibody. Two microliters of rabbit anti-G
q antiserum (Calbiochem, La Jolla, CA), 5 µl of rabbit anti-GFP (Molecular Probes), or 5 µl of rabbit anti-
subunit antibody (Calbiochem) were used for immunoprecipitation. The protein A
beads were washed three times with 1 ml of TNNB at 4°C and then three
times with 1 ml of TNNB without BSA at 4°C. The proteins were then
eluted with 80 µl of 1× reducing sample buffer by brief mixing and
boiling for 3 min. Forty microliters of eluate were then loaded on 9 or
13% SDS-PAGE gels. The gels were run at 30 mA for ~4 hr, dried onto
Whatman (Maidstone, UK) 3M paper for 1 hr at 80°C under vacuum,
exposed to a low-energy PhosphorImager screen overnight (Molecular
Dynamics, Sunnyvale, CA), and analyzed in a Storm 860 PhosphorImager
(Molecular Dynamics).
Confocal imaging of staining patterns. Cells were fixed for
20 min with 4% paraformaldehyde 48-72 hr after transfection and mounted in 60% glycerol, 5% n-propyl gallate, and PBS,
buffered to pH 7.8 with Tris. Some cells were permeabilized with Triton X-100 and treated with anti-G
primary antibody (Calbiochem) or anti-hemagglutinin (HA) primary antibody (Molecular Probes) for 1-12
hr. Staining of G
q and HA epitope-tagged PKC-
was revealed by a
Cy5-conjugated secondary antibody (Jackson ImmunoResearch, West Grove,
PA) and Texas Red-conjugated secondary antibody (Covance), respectively. Slides were scanned on an Olympus Optical (Tokyo, Japan)
Fluoview LSM confocal system typically using a 60×, numerical aperture 1.4 objective and excitation at 488 and 647 nm for GFP and
Cy5, respectively. Emissions at 510-550 and 700-775 nm were collected
on separate detectors. Optical sections were taken at 0.3 nm vertical
steps throughout the entire cell volume. Staining controls (processed
without primary antibody or nontransfected cells) were scanned under
identical machine settings to verify that the fluorescence was
specific. Cells with clumped GFP contents were excluded from analyses.
Volume reconstructions were created in Metamorph version 4.5 (Universal
Imaging). Fluorescence intensity maps were plotted for linear transects
drawn through the cytosol at the equatorial plane.
 |
RESULTS |
Selective modulation of N-type channels by galanin receptors
An example of the selectivity of Ca channel regulation by GPCRs is
afforded by comparison of the effects of activating two galanin
receptors, GalR1 and GalR2. GalR1 exhibits low affinity for the GalR2
specific agonist [D-Trp2]
galanin (Smith et al., 1997
, 1998
; Wang et al., 1997a
,b
, 1998
). GalR1 and GalR2, unlike GalR3, have been shown to be highly expressed in the hypothalamus (Smith et al., 1997
, 1998
; Wang et al.,
1997a
,b
, 1998
). We therefore examined the effects of galanin and
it analogues on Ba2+ currents in acutely
isolated neurons from the arcuate nucleus of the hypothalamus.
[D-Trp2] galanin was used to
distinguish between the effects of the two receptors.
Figure 1a demonstrates that
the application of multiple galanin receptor agonists, with the notable
exception of
[D-Trp2] galanin,
inhibited the Ba2+ current in acutely
isolated hypothalamic neurons (n = 13). This pharmacological profile suggests that activation of GalR1 receptors, but not GalR2 receptors, in these neurons is linked to inhibition of
the Ba2+ current. The inhibition was
voltage-dependent, being substantially relieved by a strong
depolarizing prepulse to +80 mV (Fig. 1b, i). Although
application of
[D-Trp2] galanin
did not produce any inhibition of the Ba2+
current (e.g., Fig. 1a), robust
[Ca]i mobilization (n = 8; data not shown) was observed, as expected from the activation of a G
q-coupled receptor. Thus, activation of GalR1 but not GalR2 receptors in hypothalamic neurons produces voltage-dependent inhibition of the Ba2+ current. However, activation
of GalR2 receptors mobilizes [Ca]i, consistent
with previous expression studies (Smith et al., 1997
, 1998
).

View larger version (20K):
[in this window]
[in a new window]
|
Figure 1.
Effects of galanin analogs on acutely
dissociated hypothalamic neurons and on HEK293 cells transiently
transfected with GalR1 or GalR2 together with N-type Ca channel
subunits ( 1B-1, 2/ , and
1b). a, Typical experiment on a
hypothalamic neuron in which the Ba2+ current was
inhibited by repeated application of different galanin analogs. All
peptides were used at 100 nM. Peak Ba2+
currents expressed in picoamperes are plotted versus time expressed in
minutes. The Ba2+ current was elicited every 20 sec
from a holding potential of 80 mV to a test potential of +10 mV for
200 msec. a, i, ii, Corresponding
currents at the times specified in the current plot. b,
i, Representative hypothalamic neuron demonstrating prepulse
facilitation of the Ba2+ current during an
application of galanin. The plot is an overlay of two current traces
during two separate voltage protocols, where the second trace (*)
contains a voltage step to a positive potential of +80 mV interspersed
between two test pulses. b, ii, Voltage protocols used
to generate the currents in b, i. c, i,
Typical experiment with an HEK293 cell expressing GalR1 and N-type Ca
channels. The Ba2+ current was inhibited by
application of galanin but not
[D-Trp2] galanin. Galanin and
[D-Trp2] galanin were used at 100 nM. The Ba2+ current was elicited using
the same protocol in a. c, ii,
Representative GalR1-expressing HEK cell demonstrating prepulse
facilitation of the Ba2+ current during an
application of galanin. The plot is an overlay of two current traces
during two separate voltage protocols in which the second trace (*)
contains a voltage step to a positive potential of +80 mV interspersed
between two test pulses. The voltage protocols used are identical to
the one illustrated in b, ii. d, Typical
experiment with a HEK293 cell expressing GalR2, OR, and N-type Ca
channels. The peak Ba2+ current was not inhibited by
application of galanin (100 nM) but was inhibited by the
application of the OR agonist U69593 (1 µM). The
Ba2+ current was elicited using the same protocol in
a.
|
|
Similar results were obtained with cloned rat galanin receptors (GalR1
and GalR2) expressed in HEK-293 cells together with the N-type Ca
channel subunits
1B-1,
2/
, and
1B. As
with the hypothalamic neurons, GalR1-expressing HEK cells showed a
large voltage-dependent inhibition of the
Ba2+ current on application of galanin or
galanin agonists (Fig. 1c). Galanin and its analogs
([1-16] galanin, M15, M32, M40, and C7) blocked the
Ba2+ current by 73.00 ± 2.70%
(n = 8), 61 ± 1.70% (n = 6),
63 ± 1.90% (n = 5), 65 ± 3.70%
(n = 7), 62 ± 2.90% (n = 5), and
81 ± 5.90% (n = 5), respectively. Application of
[D-Trp2] galanin
had no effect on the Ba2+ current in
GalR1-expressing cells (Fig. 1c). When GalR2 receptors were
expressed in HEK cells together with N-type Ca channels, neither
application of galanin (n = 9; data not shown) nor
[D-Trp2] galanin
(n = 7; Fig. 1d) produced inhibition of the
Ba2+ current, even though activation of
Gi/Go-coupled
ORs
expressed in the same cells by the
OR selective agonist
U69593 was clearly effective (Fig. 1d). Overnight
pretreatment with pertussis toxin (PTX) completely blocked inhibition
of N-type currents by galanin (n = 6; data not shown),
suggesting that GalR1 preferentially couples to G
i, G
o, or both.
Mobilization of [Ca]i was examined in HEK cells
transfected with either GalR1 or GalR2. In cells expressing GalR1,
application of galanin (n = 15) or
[D-Trp2] galanin
(n = 15) did not increase [Ca]i
(data not shown). However, application of carbachol to activate
endogenous muscarinic receptors produced [Ca]i
mobilization, and this effect could be blocked by treating the cells
with thapsigargin (data not shown). In contrast, HEK cells transfected
with GalR2 showed large increases in [Ca]i after application of
[D-Trp2] galanin
and other galanin analogs (data not shown). The mobilization of
[Ca]i after GalR2 activation was blocked by
pretreating the cells with thapsigargin (data not shown;
n = 12), suggesting that the source of Ca was from
thapsigargin-sensitive internal stores. Overnight incubation with PTX
did not block the ability of either galanin (n = 16) or
[D-Trp2] galanin
(n = 8; data not shown) to increase
[Ca]i in GalR2-expressing cells, suggesting
that GalR2 preferentially couples to a PTX-insensitive G-protein such
as G
q or G
i1.
Selectivity of Ca channel inhibition depends on structural elements
in the C terminus of the
1 subunit
Although activation of GalR2 receptors produced no inhibition of
wild-type
1B-1 Ca channels, we found that
certain modifications to the C terminus of the channel
1 subunit rendered it susceptible to
inhibition. We compared wild-type
1B-1 with
two C-terminal mutations of
1B-1. The first
C-terminal change we examined was a truncation of
1B-1 (
1875-2339). This C-terminal
truncation includes a region previously implicated in interactions with
G
i (Furukawa et al., 1998a
,b
). The second modified channel we
expressed was
2037-2087, containing a deletion encompassing a
region in
1B-1 homologous to a putative
G
binding site previously described in the C terminus of
1E (Qin et al., 1997
). We have previously shown that these C-terminal alterations have little to no effect on the
ability of a Gi/Go-coupled
receptor (
OR) to modulate the channel (Simen and Miller, 2000
).
Therefore, we used
OR in these studies as a positive control.
As expected, activation of
OR with U69593 (1 µM)
produced voltage-dependent inhibition of
Ba2+ currents in cells expressing
wild-type
1B-1, GalR2, and
OR (51 ± 3.4%
inhibition; n = 6), whereas
[D-Trp2] galanin
(100 nM) had no significant effect (2.2 ± 0.5% inhibition; n = 6; Fig. 1d).
OR
activation by U69593 also inhibited the Ba2+ current in cells expressing
1875-2339 or
2037-2087 in a voltage-dependent manner, similar
to its effects on wild-type Ca channels (Fig. 2a-c). However, in contrast
to wild-type
1B-1, activating GalR2 with
galanin (10-100 nM) elicited a robust inhibition
of the Ba2+ current in
1875-2339-expressing cells (Fig. 2a) and
2037-2087-expressing cells (Fig. 2b). The magnitude of
the inhibition of
1875-2339 and
2037-2087 seen after GalR2
activation was consistently smaller than that observed with
OR
activation (Fig. 2a,b). U69593 blocked the
Ba2+ current by 52 ± 5%
(n = 6) and 55 ± 2% (n = 6) in
1875-2339- and
2037-2087-expressing cells, respectively,
whereas galanin blocked the Ba2+ current
by 30 ± 3.2% (n = 9) and 27 ± 2%
(n = 6) in
1875-2339- and
2037-2087-expressing
cells, respectively. When larger truncations in the C terminus of
1B-1 were made (construct
1768-2339), no functional channel expression was obtained (data not shown).

View larger version (12K):
[in this window]
[in a new window]
|
Figure 2.
Effects of galanin analogs on HEK293 cells
transiently transfected with GalR2 and OR together with
1875-2339, 2037-2087, or 1B-2. In all three
instances, the Ba2+ current was inhibited by the
application of galanin (100 nM) and U69593 (1 µM). The Ba2+ current was elicited
using same protocol as in Figure 1a.
a-c, Representative currents from HEK cells expressing
1875-2339, 2037-2087, or 1B-2,
respectively, showing robust inhibition by U69593 as well as galanin.
d, i, ii, Representative traces from GalR2-,
OR-, and 1875-2339-expressing HEK293 cells, demonstrating
prepulse facilitation of the Ba2+ current during
application of U69593 and galanin, respectively. The plot is an overlay
of two current traces during two separate voltage protocols, where the
second trace (*) contains a voltage step to a positive potential of +80
mV interspersed between two test pulses. The voltage protocols used are
identical to those illustrated in Figure 1b, ii.
|
|
We also characterized the voltage dependence of the GalR2 inhibition of
1875-2339 and
2037-2087 currents using a prepulse protocol. The
inhibition of the Ba2+ current by galanin
was partially relieved by a prepulse to +80 mV (Fig. 2d).
The ratio of postpulse to prepulse currents (P2:P1) was similar for
U69593 and galanin in
1875-2339-expressing cells, 1.6 ± 0.10 (n = 5) and 1.5 ± 0.10 (n = 4),
respectively. For
2037-2087 expressing cells, somewhat lower P2:P1
ratios were observed for U69593 and galanin, 1.4 ± 0.09 (n = 5) and 1.3 ± 0.06 (n = 6),
respectively. Thus, it appears that modifications to the
1B-1 C terminus render it susceptible to
inhibition in a voltage-dependent manner by activation of GalR2
receptors, in a manner that is typically observed with G-protein
G
subunits. These data strongly suggest that G
subunits
released by GalR2 activation are capable of inhibiting
1B-1 but that the C terminus is somehow
involved in blocking these effects.
Interestingly, a C-terminal splice variant of the
1B subunit of the Ca channel
(
1B-2) was previously described (Williams et
al., 1992
).
1B-2 differs from
1B-1 in that
1B-2 is
shorter (2237 vs 2339 nucleotides) than
1B-1
and differs in its last 74 amino acids when compared with
1B-1. However, there has been little
functional description of the properties of
1B-2. We expressed
1B-2 and examined its modulation by GalR1,
GalR2, and
OR. Expression of
1B-2,
2/
,
1b,
OR, and GalR2 produced a
Ba2+ current that was inhibited by
OR.
Application of U69593 blocked the Ba2+
current (51 ± 7%; n = 7) to an extent similar to
that seen with
1B-1 (Fig. 2c). As
with
1B-1, inhibition of
1B-2 was voltage-dependent (P2:P1, 1.5 ± 0.1; n = 4). However, in contrast to
1B-1,
1B-2 was also
inhibited by the activation of GalR2. GalR2 inhibited
1B-2 Ca currents by 27 ± 0.9%
(n = 6; Fig. 2c). The modulation of
1B-2 by GalR2 was voltage-dependent, because a
strong depolarizing prepulse partially relieved the observed
inhibition. The P2:P1 ratio for galanin was 1.5 ± 0.1 in
1B-2-expressing cells (n = 4).
Overall, the prepulse ratios (P2:P1) for
1875-2339 and
1B-2 are similar to the ratios we previously
reported for
OR and
1B-1 (1.7 ± 0.13;
Simen and Miller, 1998
). The ratios for
2037-2087 are somewhat
lower, suggesting a lower degree of voltage dependence of inhibition
for this particular construct, which involved the smallest alteration
to the C terminus that we tested.
We explored the role of G
subunits in these effects by
overexpressing various wild-type and mutant G
q subunits. When we overexpressed wild-type G
i, G
o, and G
q, activation of GalR1 inhibited
1B-1 Ca currents to an extent
similar to that in the control situation (Fig.
3a, i, b). Galanin inhibited
the Ba2+ current in the presence of
overexpressed wild-type G
i by 68 ± 4.9% (n = 4), inhibited the Ba2+ current by 71 ± 3.7% (n = 6) with G
o, and inhibited the
Ba2+ current by 56 ± 5.9%
(n = 10) with G
q (Fig. 3b).
Overexpression of constitutively active G
i (G
i*) or G
o
(G
o*) reduced the inhibition produced by GalR1 when compared with
overexpression of wild-type G
i or G
o but to a lesser extent than
G
q*. When we overexpressed G
i*, galanin inhibited the
Ba2+ current by 33 ± 2.3%
(n = 8), and in the presence of G
o*, galanin inhibited the Ba2+ current by 35 ± 4.1% (n = 6; Fig. 3b). In contrast,
overexpression of constitutively active G
q (G
q*) potently blocked
the ability of GalR1 to inhibit the Ba2+
current (Fig. 3a, ii, b). Activation of GalR1 inhibited
wild-type Ca currents by 6.4 ± 2.5% (n = 12)
when G
q* was overexpressed (Fig. 3b). Overall,
overexpression of G
i or G
o yielded similar inhibition than
overexpression of G
q (p > 0.05, Bonferroni
corrected t test). However, overexpression of G
i* and
G
o* allowed for significantly more inhibition than G
q*
(p < 0.001; Bonferroni corrected t
test). Therefore, overexpression of all three constitutively active
G
species reduced inhibition to some extent, but G
q* was
significantly more effective than G
i* or G
o* in blocking inhibition.

View larger version (13K):
[in this window]
[in a new window]
|
Figure 3.
Effects of expression of different wild-type and
constitutively active G-protein subunits (denoted as G *) on the
ability of GalR1 to inhibit the Ba2+ current.
a, Typical experiment illustrating an HEK293 cell
expressing GalR1 and 1B-1 with either G q or G q*.
a, i, Currents from a typical cell expressing wild-type
G q, in which the Ba2+ current was inhibited by
application of galanin (100 nM). a, ii,
Typical cell expressing G q* in which the application of galanin no
longer inhibited the Ba2+ current. The
Ba2+ current was elicited with the same protocol as
in Figure 1a. b, Summary graph of the
inhibitory effects of galanin on the Ba2+ current in
HEK293 cells transfected with G i, G o, G q, G i*, G o*, and
G q*. Data are expressed as percent inhibition of the peak
Ba2+ current after the application of galanin (100 nM). Data are plotted as mean ± SEM. The
number of responding cells in each group is in
parentheses.
|
|
We tested the hypothesis that the actions of G
q were mediated
through the C terminus of the Ca channel by overexpressing G
q* with
either
1875-2339 or
1B-2 Ca channels to
see whether it would inhibit GalR1 modulation as it did with
1B-1. In contrast to its effects on
1B-1, overexpression of G
q* was unable to block the GalR1 mediated inhibition of either
1875-2339 or
1B-2. Galanin inhibited the
Ba2+ current in
1875-2339- and
G
q*-expressing cells by 28 ± 1.9% (n = 6) and
by 34 ± 4.8% (n = 6) in
1B-2- and G
q*-expressing cells. This should
be compared with the inability of GalR1 to inhibit
1B-1 in cells overexpressing G
q* (Fig.
3b). These results strongly suggest that the inhibitory
actions of G
q are mediated in some manner by the C terminus of the channel.
GalR2 activation causes translocation of GFP-tagged C-terminal
fragments of
1B
The above results suggest that activation of GalR2 is ineffective
in inhibiting
1B-1 Ca channels by a mechanism
involving G
q and the C terminus of the channel. However our results
clearly suggest that even though
1B-1 Ca
channel inhibition is not observed after GalR2 activation, activation
of the receptor might influence the state of the channel in a
G
q-dependent manner. To demonstrate that activation of GalR2 does
influence the
1B-1 Ca channel, the cellular
localization of various C-terminal fragments of
1B-1 fused to GFP was determined by confocal
fluorescence imaging before and after the activation of GalR2. The C
terminus of
1B-1 fused to GFP (GFP-C1; aa
1768-2339) was found to be distributed throughout the cytoplasm in
untreated tsA-201 cells but translocated to the plasma membrane and
co-localized with immunohistochemically localized G
q after
stimulation of GalR2 (Fig.
4a,b). In contrast, the C terminus of
1B-2 fused to GFP (GFP-C2; aa
1768-2237) and the GFP protein alone did not translocate to the plasma
membrane after stimulation with galanin (Fig.
4c,d,f). In addition, when cells were transfected
with the Gi/Go-coupled
µOR rather than GalR2, no translocation was noted after receptor
activation with the µOR selective agonist
[D-Ala2,N-Me-Phe4,
Gly5-ol]-enkephalin (DAMGO) (Fig. 4e),
suggesting that translocation of C1-GFP is G
q-specific.

View larger version (72K):
[in this window]
[in a new window]
|
Figure 4.
The influence of GalR2 receptor activation
on the localization of C terminal fragments of 1B. tsA-201 cells
were transfected with GFP-C1, GFP-C2, or a vector expressing the GFP
protein alone, GalR2 or µOR, G q, or G i and were then
immunostained with an anti-G q antibody and a Cy5-conjugated
secondary antibody. Data were obtained from two to five separate
transfections in each case. a, In the absence of galanin
(a, i), GFP-C1 as well as G q were seen to be randomly
distributed throughout the cytoplasm (n = 24 cells
examined). After the application of galanin (a, ii),
both G q and GFP-C1 were seen to translocate to the plasma membrane
(n = 30 cells examined). b, Left,
Line scan of GFP fluorescence through a cell expressing C1-GFP and
GalR2 without galanin application. b, Right, Line scan
of GFP fluorescence through a cell expressing C1-GFP and GalR2 with
galanin application. Note the enhancement near the plasma membrane
(arrows). c, In the absence or presence
of galanin, GFP-C2 as well as G q were seen to be randomly
distributed throughout the cytoplasm. d, Left, Line scan
of GFP fluorescence through a cell expressing C2-GFP and GalR2 without
galanin application (n = 8 cells examined).
d, Right, Line scan of GFP fluorescence through a cell
expressing C2-GFP and GalR2 with galanin application. Note the lack of
enhancement near the plasma membrane (arrows;
n = 24 cells examined). e, Left,
Line scan of GFP fluorescence through a cell expressing C1-GFP, µOR,
and G i without DAMGO application (n = 11 cells
examined). e, Right, Line scan of GFP fluorescence
through a cell expressing C1-GFP, µOR, and G i with DAMGO
application (n = 17 cells examined). f,
Left, Line scan of GFP fluorescence through a cell expressing
GFP and GalR2 without galanin application (n = 10 cells examined). f, Right, Line scan of GFP fluorescence
through a cell expressing GFP and GalR2 with galanin application
(n = 9 cells examined). YFP,
Yellow-shifted GFP.
|
|
Immunostaining with an antibody against rat G
q that does not
recognize endogenous human G
q demonstrated that, after receptor activation, G
q was localized principally at the membrane and co-localized with GFP-C1 but not with GFP-C2 (Fig. 4a, ii,
c). Translocation of these C-terminal fragments to the membrane
and co-localization with immunohistochemically localized G
q
therefore correlate with the sensitivity of
1B-1 and
1B-2 to
occlusion of G-protein modulation by G
q. Although the C terminus is
not free to undergo such translocation in the intact channel, our data
suggest that the C terminus of
1B-1 may be
tethered to the membrane proximally by virtue of its connection to
transmembrane domain IV of the channel as well as distally by virtue of
a G
q-dependent mechanism.
1B-2 may on the
other hand be tethered to the membrane only proximally. These
differences in arrangement with respect to the membrane may have
important implications for signaling (discussed below).
Maximov et al. (1999)
have shown that the C-terminal end of the
1B-1 but not the
1B-2
C terminus contains a PDZ interacting domain that interacts with
the PDZ domain of Mint-1 in neurons. To test the hypothesis that such
interactions are responsible for the differential interaction of
1B-1 and
1B-2 with
the membrane after receptor activation, we attempted to amplify Mint-1
from HEK-293 cells by reverse transcription-PCR but were unable to do
so, although human fetal brain yielded robust PCR products (data not
shown), consistent with a primarily neuronal distribution of expression
as previously described (Okamoto and Sudhof, 1997
). In addition,
overexpression of the PDZ domain of human Mint-1 failed to alter the
cellular distribution of the C1-GFP molecule before or after GalR2
activation by galanin (data not shown).
G
q binds directly to the C terminus of
1B
In an attempt to understand how G
q influences the channel in a
manner that depends on the C terminus, we sought to determine whether
G
q interacts directly with the C terminus of
1B. G
q* and various
1B C-terminal fragments fused to GFP were
co-expressed in tsA-201 cells, and immunoprecipitation experiments were
performed (Fig. 5). These fragments
included GFP-Cl, GFP-C2, aa 1871-2339 of
1B-1
(GFP-CC1), aa 1871-2237 of
1B-2 (GFP-CC2), aa
2164-2339 of
1B-1 (GFP-CCC1), aa 1768-2109
of
1B-1 (GFP-N), aa 1768-2009 of
1B-1 (GFP-NN), and aa 1768-1875 of
1B-1 (GFP-NNN). These constructs are
illustrated in Figure 5a. Note that the GFP-CCC1 construct
corresponds to the region of
1B-1 that differs
from
1B-2. Also note that the GFP-CC1
construct corresponds to the portion of
1B-1
that was deleted in the
1875-2339 construct.

View larger version (34K):
[in this window]
[in a new window]
|
Figure 5.
Immunoprecipitation experiments demonstrate G q
binding to the C terminus of 1B. tsA-201 cells were co-transfected
with various GFP fusion constructs and constitutively active rat G q
(G q*). Immunoprecipitations were then performed as described in
Materials and Methods. a, Graphical summary of the GFP
fusion constructs used in this study. Portions of the C terminus of
1B-1 and 1B-2 were
expressed as fusions with the GFP protein. Regions implicated in
G (Qin et al., 1997 ) and G i/G o (Furukawa et al., 1998a ,b )
binding are shown. b, An anti-rat G q antibody that
recognizes rat but not human G q immunoprecipitated a GFP fusion of
the C terminus of 1B-1 (GFP-C1; lane 1)
but not GFP alone (lane 2). No similar bands were
immunoprecipitated in cells transfected with GFP-C1 but not G q*
(lane 3). An immunoprecipitation of GFP-C1 with an
anti-GFP antibody from cells transfected with GFP-C1 alone is shown for
size comparison (lane 4). c,
Immunoprecipitations were also performed with an anti-GFP antibody. The
anti-GFP antibody co-immunoprecipitated G q* from cells expressing
G q* and GFP-C1 (lane 4) but not from cells
expressing G g* in the absence of GFP-C1 (lane 2). The
anti-GFP antibody also co-immunoprecipitated G y from cells
transfected with GFP-C1 as well as G y (lane 1).
Co-expression of G q* did not block G association with the C
terminus (lane 3). An immunoprecipitation of G with
an anti-G antibody is shown for size comparison (lane
5). d, Immunoprecipitation of G q in cells
overexpressing G q*, G , and various GFP fusion molecules
created from the C terminus of the 1B channel. The
construct NNN bound G q*, suggesting that aa
1768-1875 of the channel are sufficient for G q* binding.
|
|
As shown in Figure 5b, lane 1, a rat-specific anti-G
q
antibody co-immunoprecipitated GFP-C1 in cells expressing rat G
q* and GFP-C1. Anti-G
q did not
co-immunoprecipitate GFP in cells expressing G
q* and GFP (Fig.
5b, lane 2) and did not co-immunoprecipitate C1-GFP in cells
that were not expressing rat G
q* (Fig. 5b, lane 3). As a
molecular weight comparison, the GFP-C1 fragment was immunoprecipitated
by an anti-GFP antibody (Fig. 5b, lane 4).
Similar results were obtained when immunoprecipitations were performed
with an anti-GFP antibody (Fig. 5c). In cells expressing G
q*, G
1, G
3, and GFP-C1, an anti-GFP antibody
immunoprecipitated G
q* as well as G
(Fig. 5c, lane
3). The antibody co-immunoprecipitated G
alone in cells
expressing G
and GFP-C1 (Fig. 5c, lane 1) and G
q*
alone in cells expressing G
q* and GFP-C1 (Fig. 5c, lane 4). Neither G
q* nor G
was immunoprecipitated in
cells expressing G
q* and G
but no GFP-C1 (Fig. 5c, lane
2). G
1 was co-immunoprecipitated with an anti-G
antibody for
molecular weight comparison (Fig. 5c, lane 5).
To identify the region of the C terminus that interacts with G
q,
various portions of the C terminus (see Fig. 5a) were
expressed as GFP fusion molecules in tsA-201 cells along with rat
G
q*, and cell lysates were subjected to immunoprecipitations with an anti-rat G
q antibody as well as an anti-GFP antibody for molecular weight determination. As shown in Figure 5d, The GFP-C2,
GFP-NNN, GFP-NN, and GFP-N constructs co-immunoprecipitated with
G
q*, but the GFP, GFP-CC1, GFP-CC2, and GFP-CCC1 constructs did not. These results suggest that G
q binds to the C terminus of
1B-1 as well as
1B-2
and that the N-terminal portion of the C terminus is sufficient for
G
q binding. The interaction of G
q* with the C terminus of
1B is similar to the findings of Furukawa et
al. (1998a
,b
), who showed that G
i interacts with the C
terminus of
1B. This is the first
demonstration that G
q binds to Ca channels. We were unable to
directly assess the role of this portion of the C terminus by
electrophysiology, because deletion (construct
1768-2339) rendered
the channel nonfunctional (data not shown).
Immunoprecipitation of G
in cells transfected with GFP-C1 and
G
1
3 confirms the findings of Qin et al. (1997)
and Furukawa et
al. (1998a
,b
), who showed that G
interacts with the C terminus of
1B. Overexpression of G
q* failed to block
the ability of an anti-GFP antibody to immunoprecipitate G
. These
data suggest that although G
q and G
both bind to the C
terminus of
1B-1, displacement of G
binding to the C terminus by G
q is unlikely to be taking place. Our
electrophysiology experiments suggest that truncation of the C terminus
could block the ability of G
q to inhibit modulation, suggesting that
regions not required for G
q binding are also involved in producing
these effects.
The role of PKC
Binding of G
q to the N-terminal portion of the C terminus (aa
1768-1875) suggests that G
q is probably not directly involved in
the differential translocation of the C terminus of
1B-1 and
1B-2 in our
imaging experiments or the differential susceptibility of the two
channels to modulation by GalR2. However, our overexpression studies
clearly suggest that G
q is capable of occluding modulation and that
this effect of G
q is lost when regions C-terminal to this G
q
binding site are disrupted. G
q may therefore exert its effects
indirectly. Because G
q-coupled receptors can activate PKC, and PKC
can block G
effects by phosphorylation of Thr-422 on the I/II
loop of the channel (Hamid et al., 1999
), we tested the hypothesis that
PKC activation by GalR2 was involved in blocking G
effects. When
HEK-293 cells expressing
1B-1 and GalR2 were exposed to galanin and the PKC inhibitor staurosporine (1 µM) simultaneously, marked voltage-dependent inhibition
was observed (Fig. 6a).
Currents were inhibited by 49.3 ± 8.3% (n = 12),
in contrast to the lack of inhibition observed in the absence of staurosporine (Fig. 1d). Currents after a prepulse were
inhibited by 21.7 ± 1.9% (n = 12), significantly
less than the inhibition observed before a prepulse
(p < 0.05). These results suggest that the
inhibition seen in the presence of staurosporine is substantially but
not completely voltage-dependent.

View larger version (41K):
[in this window]
[in a new window]
|
Figure 6.
Involvement of PKC. a, HEK-293
cells were transfected with GalR2, 1B-1, 1b,
2/ , and CD8 . Galanin (100 nM) was applied
simultaneously with staurosporine (1 µM) at the times
indicated. In contrast to observations in the absence of staurosporine,
staurosporine and galanin caused marked current inhibition.
b, HEK-293 cells were transfected with GalR2,
1B-1, 1b, 2/ , CD8 , and cDNA for a
kinase-inactive PKC- [HA-PKC- -kinase dead (Kd)].
Expression of HA-PKC- -kd was verified by immunostaining (data not
shown). When galanin (100 nM) was applied, marked current
inhibition was observed. c, tSA-201 cells were
transfected with GalR2, C1-GFP, and HA-PKC- . In the absence of
galanin, C1-GFP and HA-PKC were found evenly distributed throughout
the cytoplasm (top panel). After exposure to
galanin, both proteins translocated to the plasma membrane
(bottom panel).
|
|
A number of groups have demonstrated that phorbol esters can increase
Ca currents and reduce G-protein modulation of Ca channels (Zhu and
Ikeda, 1994
; Stea et al., 1995
; Hamid et al., 1999
). Stea et al. (1995)
observed that staurosporine applied at 5-10 µM blocked
the effects of phorbol esters and metabotropic glutamate receptor
activation on Ca currents. PKC-
, a novel-type PKC, has been shown by
a number of groups to be activated by Gq-coupled receptors. For
example, PKC-
has been implicated in the actions of
1-adrenergic
receptors (Rohde et al., 2000
), AT1-type angiotensin receptors
(Muscella et al., 2000
), and purinergic receptors (Shirai et al.,
2000
). When HEK-293 cells were transfected with a kinase-inactive PKC-
,
1B-1, and GalR2, galanin was observed
to cause voltage-dependent inhibition of the currents. Galanin caused
31.6 ± 6.6% (n = 5) inhibition of currents
before a prepulse and 17.6 ± 6.2% inhibition of currents after a
prepulse, suggesting that the inhibition was substantially but not
completely voltage-dependent and somewhat lower in magnitude than the
inhibition observed in the presence of staurosporine (Fig.
6b).
To further confirm the involvement of PKC, tsA-201 cells were
transfected with GalR2, C1-GFP, and a hemaglutinin (HA) tagged PKC-
(HA-PKC
). In the absence of galanin, C1-GFP and HA-PKC
were
seen to be distributed throughout the cytoplasm. When cells were
exposed to galanin, both molecules translocated and were co-localized
at the cell surface (Fig. 6c). These results are consistent
with the notion that the C terminus of
1B-1 associates with PKC, possibly through a modular adapter protein (Jaken and Parker,
2000
), and associates with the membrane through such an interaction.
These experiments suggest that PKC-
is involved, but we cannot
exclude the involvement of other PKC isoforms on the basis of these experiments.
 |
DISCUSSION |
The experiments reported here seek to determine why activation of
G
q-coupled GPCRs fails to produce voltage-dependent inhibition of
N-type Ca channels. The results suggest that the G
subunit linked to
such receptors may play an essential role in producing this selectivity
and that the C terminus of the channel plays an important role in
mediating these effects. Although G
q binds to the proximal
(N-terminal) portion of the C terminus, we also observed evidence for a
functional role of the distal end of the C terminus in our
electrophysiological and imaging experiments. Although this region of
the channel appeared not to be necessary for binding G
q, both the
electrophysiological and imaging data suggest that it plays some role
in mediating the effects of G
q.
Perhaps the most compelling model to account for our results is a model
in which G
q that is associated with the proximal portion of the C
terminus of the channel locally activates PKC, which in turn
phosphorylates the channel and blocks G
-mediated inhibition (Fig.
7). PKC may indirectly associate with the
distal portion of the C terminus of the channel, possibly through
modular PDZ domain-containing adapter proteins (Jaken and Parker,
2000![]()